eEML - Electronic Essential Medicines List

export

Export

Abacavir + lamivudine

Essential medicine status

General description

INN

Abacavir + lamivudine

Medicine type

Chemical agent

EML status history

First added in 2015 (TRS 994) for Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified

Wikipedia

Abacavir + lamivudine

DrugBank

Abacavir ,
Lamivudine

Recommendations

Oral > Solid: 120 mg (as sulfate) + 60 mg tablet (dispersible, scored)

Indications

Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified